References
- Lissoni, P., Fumagalli, E., Malugani, F., Ardizzoia, A., Bucocev, R., Tancini, G. and Gardani, G.S. (2001) "Stimulation of IL-2 secretion by GM-CSF in advanced cancer patients", J. Biol. Regul. Homeost. Agents 15, 163–165.
- Crispino, S., Lissom, P., Ardizzoia, A., Barni, S., Rovelli, F. and Tancini, G. (1992) "Effects of granulocyte-macrophage colony-stimulating factor on cortisol, growth hormone, prolactin and melatonin in cancer patients", J. Biol. Regul. Homeost. Agents 6, 142–144.
- Rovelli, F., Barni, S., Tancini, G., Ardizzoia, A. and Lissom, P. (1995) "Endocrine effects of granulocyte colony-stimulating factor in cancer patients", Tumori 81, 438–439.
- Myslowska, J., Bryl, B. and Szolkiewicz, M. (1996) "Low doses of recombinant human erythropoietin raise serum interleuldn-2 levels in hemodialysis patients", J. Nephrol. 9, 30–34.
- Lissom, P., Rovelli, F., Baiocco, N., Tancini, G. and Fumagalli, L. (2001) "A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone", Anticancer Res. 21, 777–780.
- Ferrara, N., Houck, K.A., Jakeman, L.B. and Leung, D.W. (1992) "Molecular and biological properties of the vascular endothelial growth factor family of proteins", Endocrine Rev. 13, 18–32.
- Tung-Ping Pong, R., Fan, S.T. and Wong, J. (2001) "Clinical implications of circulating angiogenic factors in cancer patients", J. Clin. Oncol. 19, 1207–1225.
- Blay, J.Y., PaHardy, M., Ravaud, A., Caux, C., Negrier, S., Douillard, J.Y., Chevreau, C., Fleury, J., Ray, I., Escudier, R. and Lasset, C. (1999) "Serum VEGF is an indipendent prognostic factor in patients with metastatic renal carcinoma treated with IL-2 and/or IFN: analysis of the CRECY trial", Proc. Am. Soc. Clin. Oncol. 18, 1669, (abstr.).
- Pedram, A., Razandi, M., Hy, R.M. and Levin, E.R. (1997) "Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion", J. Biol. Chem. 272, 17097–17103.
- Bagnato, A. and Catt, K.C. (1998) "Endothelins as autocrine regulators of tumor cell growth", Trends Endocrinol. Metab. 9, 378–383.
- Shwild, D., Itin, A., Soffer, D. and Keshet, E. (1992) "Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis", Nature 359, 843–845.
- Alvarez Arroyo, MV., Castilla, M.A., Gonzales Pacheco, F.R., Tan, D., Riesco, A., Casado, S. and Carmelo, C. (1998) "Role of vascular endothelial growth factor on erythropoietin-related on endothelial cell proliferation", J. Am. Soc. Nephrol. 9, 1998–2004.
- Rizzo, J.D., Lichtin, A.E., Woolf, S.H., Seidenfeld, J., Bennet, C.L., Cella, D., Djulbegovic, B., Goode, M.J., Jakubowski, A.A., Lee, S.J., Miller, C.B., Rank, M.U., Regan, D.H., Browman, G.P. and Gordon, MS. (2002) "Use of epoetin in patients with cancer: evidence-based clinical practice guide-lines of the American Society of Clinical Oncology and the American Society of of hematology", J. Clin. Oncol. 20, 4083–4107.
- Roberts, A.B. and Sporn, A.B. (1986) "Growth factors and transformation", Cancer Surv. 5, 405–411.
- Grellier, P., Chanson, P., Casadevall, N., Abboud, S. and Schaison, G. (1996) "Remission of polycythemia vera after surgical care of acromegaly", Ann. Intern. Med. 124, 495–496.
- Frank, S.J. (2002) "GRH-somatostatin-GH", Endocrinology 143, 2–10.
- Tancini, G., Lissoni, P., Brivio, E, Rovelli, F., Fumagalli, G., Pescia, S., Vegetti, G., Rivolta, A. and Barni, S. (1994) "Abnormally high serum levels of somatomedin-C in patients with operable breast carcinoma", J. Endocrinol. Invest. 17\(Suppl. 1), 83, (abstr.).